Wilmot Cancer Center Researcher Gets Coalition Award
January 14, 2003
Mesut Muyan, D.V.M., Ph.D., a breast cancer researcher with the James P. Wilmot Cancer Center, recently received a $25,000 grant from the Breast Cancer Coalition of Rochester. Muyan will use the funds to study the regulation of estrogen responsive genes by designer proteins at will in breast cancer.
“Breast cancer is a pervasive problem in society today and we must do all that we can to help find a cure,” says Holly Anderson, Coalition president. “Dr. Muyan’s research is very important to finding a cure for estrogen-receptor negative breast cancer, which doesn’t respond to hormonal therapy and is associated with a worse prognosis for women.”
Muyan is biochemistry research associate professor at the University of Rochester Medical Center. He has been with the Medical Center since 1997 researching cell signaling and estrogen receptors in breast cancer. He is a graduate of University of Ankara, Turkey, where he earned doctoral degrees in veterinary medicine and reproduction. He graduated from the University of California at David with a doctorate in endocrinology. He continued his studies at the University of Washington in St. Louis as a post-doctoral researcher in molecular endocrinology.
“Research like this advances the understanding of how cancer cells work which helps scientists and oncologists provide better therapies and drugs for patients of today and tomorrow,” Muyan says. Nearly a third of post-menopausal women who get breast cancer are ER negative.
This grant is part of Coalition’s continuing effort to combat breast cancer. The Breast Cancer Coalition of Rochester works to make eradication of breast cancer a priority through education and advocacy, to empower women and men to participate fully in decisions relating to breast cancer, and to promote and focus research into the causes, prevention, treatment and cure of breast cancer. ##